Efficacy and safety comparison of insulin detemir plus insulin aspart versus insulin glargine plus insulin aspart in type 1 diabetes.

Trial Profile

Efficacy and safety comparison of insulin detemir plus insulin aspart versus insulin glargine plus insulin aspart in type 1 diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Feb 2017

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin glargine
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms NOVEL-1
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 May 2011 Last checked against European Clinical Trials Database record.
    • 07 Jul 2009 Actual end date (Dec 2004) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top